Axsome Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 136.01 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 7.12B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 ago...